Detalhe da pesquisa
1.
The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the "Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)" project.
Ann Gen Psychiatry
; 21(1): 52, 2022 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36567327
2.
A retrospective study on the diagnosis and treatment of dementia in patients referred to the Sagamihara Municipal Medical Center for Dementia for consultation.
Psychogeriatrics
; 20(3): 247-253, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31797487
3.
Second-Generation Antipsychotic Monotherapy Contributes to the Discontinuation of Anticholinergic Drugs in Hospitalized Patients With Schizophrenia.
J Clin Psychopharmacol
; 42(6): 591-593, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36193896
4.
Influence of Psychotropic Pro Re Nata Drug Use on Outcomes in Hospitalized Patients with Schizophrenia.
Clin Psychopharmacol Neurosci
; 21(2): 332-339, 2023 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37119226
5.
The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE project.
Asian J Psychiatr
; 69: 103007, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35051727
6.
Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project.
Asian J Psychiatr
; 63: 102744, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34325252
7.
Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study.
Neuropsychopharmacol Rep
; 41(2): 199-206, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33704931